Medline (MDLN) Invested Capital (2024 - 2026)

Medline (MDLN) has 3 years of Invested Capital data on file, last reported at $11.3 billion in Q1 2026.

• Quarterly Invested Capital changed N/A year-over-year to $11.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 billion (changed N/A YoY) and the FY2025 annual result came in at $10.8 billion, down 33.39% from the prior year.
• Invested Capital improved to $11.3 billion in Q1 2026 per MDLN's latest filing, from $10.8 billion in the prior quarter.
• Across five years, Invested Capital topped out at $16.2 billion in Q4 2024 and bottomed at $10.8 billion in Q4 2025.
• The 3-year median for Invested Capital is $11.3 billion (2026), against an average of $12.8 billion.
• Peak annual rise in Invested Capital reached 33.39% in 2025, while the deepest fall reached 33.39% in 2025.
• Tracing MDLN's Invested Capital over 3 years: stood at $16.2 billion in 2024, then tumbled by 33.39% to $10.8 billion in 2025, then increased by 4.95% to $11.3 billion in 2026.
• Per Business Quant, the three latest MDLN Invested Capital figures stand at $11.3 billion (Q1 2026), $10.8 billion (Q4 2025), and $16.2 billion (Q4 2024).

Peer Comparison